32 Biggest Movers From Yesterday

Gainers

• ChinaNet Online Holdings, Inc. CNET shares gained 27.53 percent to close at $3.15 on Tuesday following Q4 results. ChinaNet Online reported a Q4 loss of $0.50 per share on revenue of $15.43 million.
• China Internet Nationwide Financial Services Inc. CIFS rose 22.65 percent to close at $21.82.
• IntriCon Corporation IIN shares gained 20.92 percent to close at $23.70. Stifel Nicolaus initiated coverage on IntriCon with a Buy rating and a $35.00 price target.
• Calyxt, Inc. CLXT shares rose 20.86 percent to close at $17.38 on Tuesday.
• Check-Cap Ltd. CHEK gained 20.05 percent to close at $4.97.
• ArQule, Inc. ARQL shares jumped 17.04 percent to close at $3.16. ArQule licensed derazantinib to Basilea Pharma for the development and commercialization outside of China.
• Ritter Pharmaceuticals, Inc. RTTR shares rose 13.5 percent to close at $3.2117.
• Fred's, Inc. FRED climbed 13.29 percent to close at $3.24. Fred's rescheduled its conference call to discuss its Q4 financial results to May 4, 2018.
• G1 Therapeutics, Inc. GTHX rose 12.1 percent to close at $40.68 on Tuesday.
• OncoCyte Corporation OCX shares gained 12 percent to close at $2.80
• Twitter, Inc. TWTR rose 11.41 percent to close at $31.84. Morgan Stanley upgraded Twitter from Underweight to Equal-Weight.
• Carvana Co. CVNA climbed 11.36 percent to close at $30.10. Carvana Co announced the acquisition of augmented reality startup Car360.
• GW Pharmaceuticals plc GWPH shares surged 11.24 percent to close at $134.13.
• Netflix, Inc. NFLX climbed 9.19 percent to close at $336.06 after the company reported better-than-expected sales for its first quarter Net streaming additions came in at 7.41 million, also beating estimates by nearly 1 million. The company issued strong second-quarter guidance.
• J.Jill, Inc. JILL shares gained 8.67 percent to close at $5.32.
• Akoustis Technologies, Inc. AKTS shares rose 7.74 percent to close at $5.29.
• InfoSonics Corporation IFON shares climbed 7.44 percent to close at $5.34.
• GrubHub Inc. GRUB gained 5.3 percent to close at $103.72. Stephens & Co. initiated coverage on GrubHub with an Overweight rating.
• Celanese Corporation CE rose 3.72 percent to close at $110.38 after the company reported stronger-than-expected results for its first quarter on Monday.
• UnitedHealth Group Incorporated UNH gained 3.57 percent to close at $238.54 after the company reported better-than-expected earnings for its first quarter and raised its FY 2018 guidance.

Losers

• Netlist, Inc. NLST shares tumbled 25.86 percent to close at $0.18 on Tuesday following an initial ITC determination to grant SK Hynix motion for summary determination of non-infringement and termination of 1089 probe. Roth Capital downgraded Netlist from Buy to Neutral.
• Apellis Pharmaceuticals, Inc. APLS shares declined 16.6 percent to close at $25.02 after the company reported proposed offering of common stock.
• Odyssey Marine Exploration, Inc. OMEX shares dropped 15.88 percent to close at $9.59.
• Bellicum Pharmaceuticals, Inc. BLCM fell 12.6 percent to close at $7.84 after the company reported a 7 million-share common stock offering.
• GoPro, Inc. GPRO tumbled 9.68 percent to close at $5.04.
• Sears Holdings Corporation SHLD shares slipped 9.55 percent to close at $3.03.
• REV Group, Inc. REVG fell 8.81 percent to close at $18.42.
• Image Sensing Systems, Inc. ISNS shares declined 7.92 percent to close at $4.65.
• Cryoport, Inc. CYRX shares fell 7.73 percent to close at $7.64 on Tuesday.
• DropCar, Inc. DCAR shares dropped 7.25 percent to close at $1.92.
• SeaChange International, Inc. SEAC dropped 7.17 percent to close at $2.85 after reporting a fourth-quarter earnings and sales beat, but downbeat guidance.
• Anavex Life Sciences Corp. AVXL shares declined 6.28 percent to close at $2.09 after the company announced plans to initiate a Phase 2 clinical trial of lead candidate ANAVEX®2-73 in Parkinson’s Disease Dementia. Anavex Life Sciences submitted an investigational new drug application to the FDA for ANAVEX 2-73 Phase 2 in Rett syndrome.